Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1742.00 | 1826.25 | 0.9539 | 0.9297 | |
| SK-BR-3 | 0 | uM | 5 | 1250.00 | 731.83 | 1796.00 | 1826.25 | 0.9834 | 0.9748 | |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3688.00 | 3831.25 | 0.9626 | 0.9433 | |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3921.00 | 3831.25 | 1.0234 | 1.0353 | |
| SK-BR-3 | Etoposide | 10 | uM | 5 | 2500.00 | 1529.25 | 1908.00 | 3831.25 | 0.4980 | 0.1818 |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3809.00 | 3831.25 | 0.9942 | 0.9912 | |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3919.00 | 3831.25 | 1.0229 | 1.0345 | |
| SK-BR-3 | Etoposide | 1 | uM | 5 | 2500.00 | 1529.25 | 1980.00 | 3831.25 | 0.5168 | 0.2153 |
| SK-BR-3 | NVP-TAE684 | 0.31623 | uM | 5 | 2500.00 | 1529.25 | 3867.00 | 3831.25 | 1.0093 | 1.0141 |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 5 | 2500.00 | 1529.25 | 3980.00 | 3831.25 | 1.0388 | 1.0583 |
| SK-BR-3 | Nilotinib | 3.1623 | uM | 5 | 2500.00 | 1529.25 | 3951.00 | 3831.25 | 1.0313 | 1.0470 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 5 | 2500.00 | 1529.25 | 4083.00 | 3831.25 | 1.0657 | 1.0984 |
| SK-BR-3 | NVP-TAE684 | 0.0033113 | uM | 5 | 2500.00 | 1529.25 | 4062.00 | 3831.25 | 1.0602 | 1.0903 |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 4106.00 | 3831.25 | 1.0717 | 1.1073 | |
| SK-BR-3 | Etoposide | 0.1 | uM | 5 | 2500.00 | 1529.25 | 3682.00 | 3831.25 | 0.9610 | 0.9409 |
| SK-BR-3 | PLX-4720 | 0.0033113 | uM | 5 | 2500.00 | 1529.25 | 3996.00 | 3831.25 | 1.0430 | 1.0646 |
| SK-BR-3 | Nilotinib | 0.0033113 | uM | 5 | 2500.00 | 1529.25 | 3866.00 | 3831.25 | 1.0091 | 1.0137 |
| SK-BR-3 | PLX-4720 | 0.31623 | uM | 5 | 2500.00 | 1529.25 | 3763.00 | 3831.25 | 0.9822 | 0.9731 |
| SK-BR-3 | NVP-TAE684 | 0.031623 | uM | 5 | 2500.00 | 1529.25 | 3581.00 | 3831.25 | 0.9347 | 0.9006 |
| SK-BR-3 | Nilotinib | 0.31623 | uM | 5 | 2500.00 | 1529.25 | 4174.00 | 3831.25 | 1.0895 | 1.1336 |
| SK-BR-3 | NVP-TAE684 | 1 | uM | 5 | 2500.00 | 1529.25 | 3788.00 | 3831.25 | 0.9887 | 0.9829 |
| SK-BR-3 | Etoposide | 0.031623 | uM | 5 | 2500.00 | 1529.25 | 3875.00 | 3831.25 | 1.0114 | 1.0172 |
| SK-BR-3 | PLX-4720 | 1 | uM | 5 | 2500.00 | 1529.25 | 3961.00 | 3831.25 | 1.0339 | 1.0509 |
| SK-BR-3 | PLX-4720 | 0.031623 | uM | 5 | 2500.00 | 1529.25 | 3834.00 | 3831.25 | 1.0007 | 1.0011 |
| SK-BR-3 | 0 | uM | 5 | 2500.00 | 1529.25 | 3626.00 | 3831.25 | 0.9464 | 0.9186 |